MedPath

海南海药股份有限公司海口市制药厂

Ownership
-
Established
1990-03-09
Employees
-
Market Cap
-
Website
http://www.haiyao.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

144

NMPA:144

Drug Approvals

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20253575
Approval Date
Mar 11, 2025
NMPA

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20253574
Approval Date
Mar 11, 2025
NMPA

Cefaclor for Suspension

Product Name
头孢克洛干混悬剂
Approval Number
国药准字H20249785
Approval Date
Dec 25, 2024
NMPA

Ceftriaxone Sodium for Injection

Product Name
注射用头孢曲松钠
Approval Number
国药准字H20023340
Approval Date
Aug 16, 2024
NMPA

桑菊感冒片

Approval Number
国药准字Z46020064
Approval Date
Jul 30, 2024
NMPA

Oenothera Biennis Oil Soft Capsules

Product Name
月见草油胶丸
Approval Number
国药准字H46020587
Approval Date
Jul 4, 2024
NMPA

枫蓼肠胃康口服液

Approval Number
国药准字Z20090296
Approval Date
Nov 13, 2023
NMPA

Cefodizime Sodium for Injection

Product Name
注射用头孢地嗪钠
Approval Number
国药准字H20183502
Approval Date
Oct 24, 2023
NMPA

Cefodizime Sodium for Injection

Product Name
注射用头孢地嗪钠
Approval Number
国药准字H20183503
Approval Date
Oct 24, 2023
NMPA

Vitamin C for Injection

Product Name
注射用维生素C
Approval Number
国药准字H20093561
Approval Date
Oct 11, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.